Vitura Health Ltd (ASX: VIT) Share Price and News

Mr Tanner is an experienced and driven Executive and Director with a track record over years of operating in multiple industries and markets. Shane was formerly inaugural CEO of Symbion Health (formerly known as Mayne Nickless Diagnostic Services). He also played a role in the float of Optus Communications. Over the past 20 years, Shane has been involved with multiple IPO's (including Vitura in November 2019) and mergers and acquisitions. He has served as either the Chair or Non-Executive Director on more than ten public company boards and many other private companies. He currently chairs an Australian company that is a global leader in the nuclear waste treatment industry, which includes working with the US Government in this space. Other Directorships include Lokaway Pty Ltd (Chair), GeoRoc International Inc (Chair), Gravitas Technologies Ltd (Chair). He is chair of risk committee.

Ms Wilson is an experienced company director with private, ASX-listed and not-for-profit organisations. She is currently a Non-Executive Director of not for-profit Tomisich Foundation and Veski. In an executive career spanning 25 years, Rebecca held global leadership roles in marketing communication, brand positioning, investor relations, capital management, and corporate affairs. She has experience in ESG, stakeholder communication, brand awareness, issues, crisis and risk management, transactions, and investor relations. Rebecca is industry agnostic, having worked with multinational and growth companies in technology, healthcare, retail and FMCG, and professional services. She has experience leading companies in commercial activation phases working with CEOs as both an advisor and Non-Executive Director to develop and execute effective business strategy that supports accelerated and sustained growth. She's worked as a NED since 2017, including Committee representation on Remuneration and Nominations (including as Chair), M&A, ESG, and Audit and Risk. In addition to her non-executive boards, she continues to provide consulting services to boards and executive management teams.

Mr Iervasi, as the former Group CEO and Director of Asahi Beverages, led a consumer products / FMCG business with more than $5 billion in annual revenue and over 5,000 employees, including a manufacturing footprint. Prior to this, Robert served as the Group COO and CFO and General Counsel of Asahi for over eight years, managing Finance, Shared Business Services, Legal, Risk Strategy and Information Technology, as well Sales, Marketing, Supply Chain and Science and Innovation and has driven profitability and growth across multiple categories, brands and channels. In 2020, he identified and executed the acquisition by Asahi of Carlton & United Breweries. Robert brings experience in governance, finance, law, and innovation to Vitura. Prior to joining Asahi, Robert held senior positions with Cadbury Schweppes and Coles Group and was principal legal advisor for the Kmart business in Australia and New Zealand. He is member of Risk Committee. Other Directorships include Luv-a-Duck Pty Ltd (Chair), Charters Paper Pty Ltd (Executive Chair).

Mr Fogarty is an experienced non-executive director and CEO. His board and executive roles have encompassed a variety of sectors, including national security, industrial relations regulation, work health and safety regulation, compensation and rehabilitation regulation, medical research, human performance research and health insurance. His background spans entities, including statutory authorities, joint ventures, industry bodies, not-for-profits and advisory boards. He was most recently a CEO of a private health insurer, leading it to repeated national customer satisfaction and employer of choice awards.

Mr Birch is a commercially astute and experienced lawyer with nearly two decades of experience in delivering strategic legal counsel across industries, providing informed, solution-driven advice. Daniel's experience includes advising companies in the Medicinal Cannabis and scheduled drugs sectors, serving as the primary legal advisor to CDA Health and its subsidiaries prior to its merger with Vitura in December 2021. His understanding of regulated industries, compliance frameworks, and distribution operations makes him an asset in navigating legal landscapes. Daniel is Partner and Head of Commercial and Corporate at Stone Group Lawyers. His knowledge and strategic insights position him as a trusted advisor in the legal and corporate arenas. He is member of Risk Committee.

-

-

-

-

-